IBM director defers fees into 309 Promised Fee Shares
International Business Machines Corporation (IBM) director A. W. Zollar reported a compensation-related transaction involving deferred stock-based fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
International Business Machines Corporation (IBM) director A. W. Zollar reported a compensation-related transaction involving deferred stock-based fees. On 12/31/2025, Zollar acquired 309 Promised Fee Shares as a derivative security at a conversion or exercise price of $0.00, bringing total derivative securities beneficially owned to 9,119 held directly.
The Promised Fee Shares are granted under the IBM Board of Directors Deferred Compensation and Equity Award Plan
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Promised Fee Share | 309 | $296.21 | $92K |
Footnotes (3)
- F1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.
- F2. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.
- F3. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IBM (IBM) director A. W. Zollar report?
Director A. W. Zollar reported acquiring 309 Promised Fee Shares as a derivative security on 12/31/2025 under IBM’s director deferred compensation plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.